← Insider buys
RETA

Reata Pharmaceuticals Inc

Chief Development Officer Keith Wayne Ward sold $224K of Reata Pharmaceuticals Inc

Sold$224,045
$53.99Price
4,150Shares
−100%Stake

What RETA did after the filing

Prices for RETA after this filing aren't in yet.

Traded Wed, Jan 2. Filed Thu, Jan 3. Not investment advice.